Smiths S. Lueong

Bridge Institute Of Experimental Tumor Therapy And Division Of Solid Tumor Translational Oncology
Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Early recurrence prediction after curative-intent surgery of intrahepatic cholangiocarcinoma using a novel weighted tumor burden score.

Early recurrence prediction after curative-intent surgery of intrahepatic cholangiocarcinoma using a novel weighted tumor burden score.

Journal: World journal of surgical oncology

Published: June 03, 2026

Inflammation and RNA-Related Polymorphisms in Resected Cholangiocarcinoma: Prognostic Associations in Intrahepatic and Perihilar Tumors.

Inflammation and RNA-Related Polymorphisms in Resected Cholangiocarcinoma: Prognostic Associations in Intrahepatic and Perihilar Tumors.

Journal: Journal of gastrointestinal cancer

Published: May 13, 2026

Preoperative quality of life in patients undergoing liver surgery.

Preoperative quality of life in patients undergoing liver surgery.

Journal: Surgery open science

Published: January 10, 2026

Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM).

Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM).

Journal: iScience

Published: May 23, 2025

The Prognostic Value of the XPC rs2228001 Single Nucleotide Polymorphism in Cholangiocarcinoma.

The Prognostic Value of the XPC rs2228001 Single Nucleotide Polymorphism in Cholangiocarcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 11, 2025

Gut microbiota deficiency reduces neutrophil activation and is protective after ischemic stroke.

Gut microbiota deficiency reduces neutrophil activation and is protective after ischemic stroke.

Journal: Journal of neuroinflammation

Published: February 02, 2025

ABO-Blood Group Associates With Survival Outcomes in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.

ABO-Blood Group Associates With Survival Outcomes in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.

Journal: Thoracic cancer

Published: January 21, 2025

BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOK.

BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOK.

Journal: Cells

Published: December 27, 2024

Key Regulatory Elements of the TGFβ-LRRC15 Axis Predict Disease Progression and Immunotherapy Resistance Across Cancer Types.

Key Regulatory Elements of the TGFβ-LRRC15 Axis Predict Disease Progression and Immunotherapy Resistance Across Cancer Types.

Journal: bioRxiv : the preprint server for biology

Published: December 09, 2024

Editorial: Liquid biopsy in oncology: opportunity and challenges.

Editorial: Liquid biopsy in oncology: opportunity and challenges.

Journal: Frontiers in molecular biosciences

Published: July 18, 2024

PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors.

PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 26, 2024

Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell-free RNA.

Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell-free RNA.

Journal: Molecular oncology

Published: March 03, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026